1. Home
  2. JBDI vs CASI Comparison

JBDI vs CASI Comparison

Compare JBDI & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBDI
  • CASI
  • Stock Information
  • Founded
  • JBDI 1983
  • CASI 1991
  • Country
  • JBDI Singapore
  • CASI China
  • Employees
  • JBDI N/A
  • CASI N/A
  • Industry
  • JBDI
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • JBDI
  • CASI Health Care
  • Exchange
  • JBDI Nasdaq
  • CASI Nasdaq
  • Market Cap
  • JBDI 20.8M
  • CASI 20.5M
  • IPO Year
  • JBDI 2024
  • CASI 1996
  • Fundamental
  • Price
  • JBDI $1.03
  • CASI $2.38
  • Analyst Decision
  • JBDI
  • CASI Strong Buy
  • Analyst Count
  • JBDI 0
  • CASI 1
  • Target Price
  • JBDI N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • JBDI 22.0K
  • CASI 3.7M
  • Earning Date
  • JBDI 01-01-0001
  • CASI 08-26-2025
  • Dividend Yield
  • JBDI N/A
  • CASI N/A
  • EPS Growth
  • JBDI N/A
  • CASI N/A
  • EPS
  • JBDI N/A
  • CASI N/A
  • Revenue
  • JBDI $9,017,000.00
  • CASI $31,368,000.00
  • Revenue This Year
  • JBDI N/A
  • CASI N/A
  • Revenue Next Year
  • JBDI N/A
  • CASI N/A
  • P/E Ratio
  • JBDI N/A
  • CASI N/A
  • Revenue Growth
  • JBDI N/A
  • CASI 8.39
  • 52 Week Low
  • JBDI $0.49
  • CASI $1.09
  • 52 Week High
  • JBDI $39.41
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • JBDI N/A
  • CASI 70.81
  • Support Level
  • JBDI N/A
  • CASI $1.46
  • Resistance Level
  • JBDI N/A
  • CASI $2.03
  • Average True Range (ATR)
  • JBDI 0.00
  • CASI 0.35
  • MACD
  • JBDI 0.00
  • CASI 0.07
  • Stochastic Oscillator
  • JBDI 0.00
  • CASI 61.75

About JBDI JBDI Holdings Limited Ordinary Shares

JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. Its products include Reconditioned and new steel drums, plastic drums, carboys and IBCs.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: